NCT06959459View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of Artificial Bone Repair Materials for Repair of Long Bone Defects in the Extremities

NANot yet recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

May 10, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

December 30, 2026

Conditions
Bone Defects of the Limbs
Interventions
DEVICE

Intervention Group:Use of artificial bone repair materials produced by Changzhou Bone-Renewal Medical Technologies LLC.

Use of artificial bone repair materials produced by Changzhou Bone-Renewal Medical Technologies LLC.

DEVICE

Control group: Use of β-tricalcium phosphate bioceramics produced by Shanghai Biolu Biomaterials Co., Ltd.

Use of β-tricalcium phosphate bioceramics produced by Shanghai Biolu Biomaterials Co., Ltd.

Trial Locations (1)

Unknown

Chinese PLA General Hosptial, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT06959459 - Evaluation of the Safety and Efficacy of Artificial Bone Repair Materials for Repair of Long Bone Defects in the Extremities | Biotech Hunter | Biotech Hunter